Compass therapeutics to participate in the leerink partners global biopharma conference

Boston, feb. 29, 2024 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the company will participate in the leerink partners global biopharma conference in miami beach, florida on wednesday, march 13, 2024.
CMPX Ratings Summary
CMPX Quant Ranking